Goodrx Holdings, Inc. (GDRX) — 10-Q Filings
All 10-Q filings from Goodrx Holdings, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
GoodRx's Q3 Net Income Plunges 72% Amid Rising Costs
— Nov 4, 2025 Risk: high
GoodRx Holdings, Inc. (GDRX) reported a mixed financial performance for the three and nine months ended September 30, 2025. For the three months, revenue increa -
GoodRx Swings to Profit on Strong Revenue Growth, Cost Cuts
— Aug 6, 2025 Risk: medium
GoodRx Holdings, Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $200.5 million, up from $180.0 million in th -
GoodRx Holdings Files Q1 2025 10-Q
— May 7, 2025 Risk: medium
GoodRx Holdings, Inc. filed its quarterly report for the period ending March 31, 2025. The filing details financial performance and operational updates for the -
GoodRx Holdings, Inc. Files Q3 2024 10-Q Report
— Nov 7, 2024 Risk: medium
GoodRx Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third qu -
GoodRx Holdings Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
GoodRx Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarte -
GoodRx Holdings, Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
GoodRx Holdings, Inc. (GDRX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. GoodRx Holdings, Inc. filed a 10-Q report for the period ending March
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX